Shopping Cart
Remove All
Your shopping cart is currently empty
Izeltabart (MGA021) is a humanised monoclonal antibody targeting ADAM9, utilised in the synthesis of the ADC molecule Izeltabart Tapatansine (IMGC936).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $247 | - | In Stock | |
| 5 mg | $647 | - | In Stock | |
| 10 mg | $987 | - | In Stock |
| Description | Izeltabart (MGA021) is a humanised monoclonal antibody targeting ADAM9, utilised in the synthesis of the ADC molecule Izeltabart Tapatansine (IMGC936). |
| In vitro | The ADC molecule IMGC936 exhibits antitumor effects and is formed by the conjugation of Izeltabart and DM21. [1] |
| Synonyms | MGA-021, MGA021, IMGC-936 Antibody, IMGC936 Antibody |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 2642078-60-0 |
| Color | Transparent |
| Appearance | Liquid |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.